Biomedical Research Institute

The Biomedical Research Institute (BRI) is a 501 c-3 nonprofit research company committed to improving global health through a variety of research and service activities. For over 40 years, with the financial support of the NIH, our mission has been to reduce the global health burden imposed by infectious diseases of the developing world in general, and targeting Schistosomiasis, a deadly parasitic disease in particular.  This disease is responsible for 250,000 deaths annually, while also causing significant morbidity primarily in sub-Saharan Africa and parts of Mediterranean Europe, South America and rural China.  More…

Schistosomiasis

According to the Centers for Disease Control (CDC), World Health Organization (WHO), Carter Center, and National Institutes of Health (NIH), Schistosomiasis is a major public health problem in many tropical countries worldwide.  After malaria, it is one of the most devastating parasitic diseases of man.  The WHO estimates that Schistosomiasis afflicts approximately 300 million people globally, with more than 800 million at risk of infection annually; 95% of the cases occur in Sub-saharan Africa.  In many countries, Schistosomiasis ranks near the top in causes of morbidity associated with infectious disease.  In addition to the substantial health burdens associated with the disease, especially in children and young adults, Schistosomiasis places a severe strain on primary health care facilities and limits the overall economic development of an afflicted region.  Clearly, further research efforts are essential for reducing the impact of this helminthic infection as a public health menace. More…

Biorepository Services

BRI has close to 70 years of experience in cryobiology. Incorporated in 1948 in Chicago, IL and originally operating under the name of the American Foundation for the Study of Genetics in Wisconsin, the organization pioneered the cryopreservation of bovine semen and human blood products which is the foundation of modern day in vitro fertilization for agricultural purposes and storage of blood products, respectively.

Renamed American Foundation for Biological Research (AFBR) in 1956 – and doing business in the state of Maryland since the late 1960s as Biomedical Research Institute (BRI),  BRI has provided researchers and institutions around the world with low temperature storage space for medical specimens. Our capabilities to store and distribute precious biomaterials help speed research and hasten the discovery of cures and treatments.  More…